AnaptysBio Inc (ANAB) is gearing up for another turning point as it hit the volume of 0.54 million

On Tuesday, AnaptysBio Inc (NASDAQ: ANAB) opened higher 2.45% from the last session, before settling in for the closing price of $20.03. Price fluctuations for ANAB have ranged from $12.21 to $41.31 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Healthcare Sector giant saw their annual sales surged by 247.37% over the last five years. Company’s average yearly earnings per share was noted -1.09% at the time writing. With a float of $27.10 million, this company’s outstanding shares have now reached $30.39 million.

The firm has a total of 136 workers. Let’s measure their productivity. In terms of profitability, gross margin is 98.94%, operating margin of -89.64%, and the pretax margin is -125.66%.

AnaptysBio Inc (ANAB) Insider Activity

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of AnaptysBio Inc is 7.76%, while institutional ownership is 125.56%. The most recent insider transaction that took place on Dec 30 ’24, was worth 842,060. In this transaction Director of this company bought 65,184 shares at a rate of $12.92, taking the stock ownership to the 7,860,180 shares. Before that another transaction happened on Dec 31 ’24, when Company’s Director bought 13,268 for $12.93, making the entire transaction worth $171,513. This insider now owns 7,873,448 shares in total.

AnaptysBio Inc (ANAB) Earnings and Forecasts

According to the Wall Street analysts, stocks earnings will be around -1.09% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.85% during the next five years compared to -7.30% drop over the previous five years of trading.

AnaptysBio Inc (NASDAQ: ANAB) Trading Performance Indicators

Check out the current performance indicators for AnaptysBio Inc (ANAB). In the past quarter, the stock posted a quick ratio of 8.25. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.39.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.84, a number that is poised to hit -1.50 in the next quarter and is forecasted to reach -4.65 in one year’s time.

Technical Analysis of AnaptysBio Inc (ANAB)

Analysing the last 5-days average volume posted by the [AnaptysBio Inc, ANAB], we can find that recorded value of 0.54 million was lower than the volume posted last year of 0.91 million. As of the previous 9 days, the stock’s Stochastic %D was 39.60%. Additionally, its Average True Range was 1.33.

During the past 100 days, AnaptysBio Inc’s (ANAB) raw stochastic average was set at 80.64%, which indicates a significant increase from 50.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.60% in the past 14 days, which was lower than the 84.36% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $18.66, while its 200-day Moving Average is $23.86. Now, the first resistance to watch is $21.20. This is followed by the second major resistance level at $21.88. The third major resistance level sits at $22.79. If the price goes on to break the first support level at $19.61, it is likely to go to the next support level at $18.70. Should the price break the second support level, the third support level stands at $18.02.

AnaptysBio Inc (NASDAQ: ANAB) Key Stats

There are currently 29,380K shares outstanding in the company with a market cap of 602.89 million. Presently, the company’s annual sales total 91,280 K according to its annual income of -145,230 K. Last quarter, the company’s sales amounted to 27,770 K and its income totaled -39,330 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.